GTC Biotherapeutics (fka GTCB)

[shears]

Let's see if I get this straight. GTCB just shelled out $1M for the rights to a $3B market. The only reason they pulled this off is by having locked up the patent rights to transgenic milk production of proteins and the nuts to enforce those patents in North America, EU, and Japan - also the most lucrative markets where higher prices can be had. $0.94/shr looks even more ridiculously cheap than it did before this deal. Who cares about the $1M? That's peanuts. This is a great big huge deal for GTCB. I wonder when the market will wake up to the implications? The plasma derived market for these products will dry up - driven out of business due to risk and the competitive pressures of the much lower cost production platform of the transgenic proteins. Future profits from a $3B market a couple of years down the road should jack the price of GTCB up at least a couple bucks if you ask me.